We are live on ! Find out more
PKBOW

Peak Bio, Inc. Warrant
PKBOW

Delisted

PKBOW was delisted on the 5th of January, 2023.

11 hedge funds and large institutions have $795K invested in Peak Bio, Inc. Warrant in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more funds holding

Funds holding: 811 (+3)

9% more capital invested

Capital invested by funds: $727K → $795K (+$68K)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
11
Holders Change
+3
Holders Change %
+37.5%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

PKBOW Hedge Fund Activity: Q2 2021 in Review

11 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Peak Bio, Inc. Warrant (PKBOW) for Q2 2021, worth a combined $795K — up 9.4% from $727K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new PKBOW positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Davidson Kempner Capital Management, opening a new position worth an estimated $66.8K. The largest seller was Polar Asset Management Partners, cutting an estimated $8.53K.

  • 11 institutional investors held Peak Bio, Inc. Warrant (PKBOW) as of Q2 2021, up from 8 in Q1 2021.
  • Funds reported $795K of Peak Bio, Inc. Warrant stock for Q2 2021, up 9.4% quarter-over-quarter.
  • 3 funds opened new Peak Bio, Inc. Warrant positions in Q2 2021 and 0 closed out, a net change of +3 holders.
  • The largest Peak Bio, Inc. Warrant buyer in Q2 2021 was Davidson Kempner Capital Management, an estimated $66.8K added.
  • The largest Peak Bio, Inc. Warrant seller in Q2 2021 was Polar Asset Management Partners, an estimated $8.53K sold.

Based on aggregated 13F filings for Q2 2021.